Search Results

You searched for : BARDA  

CDC says 3 feet of distance enough for schoolers

New school safety guidelines from CDC...
Mar 20

FUJIFILM Diosynth Biotechnologies begins production of two COVID-19 vaccines

FUJIFILM Diosynth Biotechnologies announced that production has begun in Texas on two different COVID-19 vaccine candidates with support from the U.S. government...
Jan 19

Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its VITROS® SARS-CoV-2 Antigen Test, designed to detect active infection, ...
Jan 13

Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses

The new agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing the total potential U.S. supply to over ...
Jan 13

RedHill's phase 2/3 COVID-19 study of opaganib passes second DSMB with unanimous recommendation to continue

Opaganib potentially minimizes likelihood of resistance due to viral mutations by targeting a human cell component involved in viral replication ...
Dec 22

The RedHill Phase II / III candidate opaganib reduces ARDS-related blood clotting in the preclinical model in COVID-19 patients

The results also show that opaganib inhibits SARS-CoV-2 virus replication and proinflammatory markers in relevant preclinical models ...
Dec 17

Moderna announces amendment to supply agreement of COVID vaccine with the ministry of health of Israel

This agreement will support the ongoing efforts by the Ministry to secure early access to a COVID-19 vaccine for the people of Israel...
Dec 05

Regeneron's REGEN-COV2 is first antibody cocktail for COVID-19 to receive US FDA emergency use authorization

The clinical evidence from Regeneron's outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis ...
Nov 23

RedHill announces DSMB unanimous recommendation to continue COVID-19 opaganib phase 2/3 study

The independent, pre-programmed DSMB unanimously recommends the continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia...
Nov 23

European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older

The European Commission has granted marketing authorization for Supemtek®, a quadrivalent (four-strain) recombinant influenza vaccine, for the prevention of influenza in adults aged 18 ...
Nov 20

Moderna Announces Supply Agreement with United Kingdom Government to Supply mRNA Vaccine Against COVID-19

This agreement comes as the UK continues its efforts to secure access to safe and effective COVID-19 vaccines...
Nov 19

Regeneron’s Antibody cocktail REGN-EB3 (Inmazeb) is first FDA-Approved treatment for Ebola

First FDA approved antibody treatment for Ebola...
Oct 19

Trump Administration Expands Collaboration with AstraZeneca to Develop and Manufacture an Investigational Monoclonal Antibody to Prevent COVID-19

The goal of AstraZeneca's partnership with the U.S. Government is to develop a monoclonal antibody cocktail that can help prevent infection....
Oct 10

COVID-19 AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials

The combination of two LAABs is also designed to reduce the risk of resistance developed by the SARS-CoV-2 virus....
Oct 09

COVID-19 AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials

The combination of two LAABs is also designed to reduce the risk of resistance developed by the SARS-CoV-2 virus....
Oct 09

NIH RADx initiative advances six new COVID-19 testing technologies

...
Oct 07

Regeneron Pharma announced, result of Phase 1/2/3 trial of antibody cocktail REGN-COV2

Regenerons REGN-COV2 antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients...
Oct 02

Veeva and Bioforum partner with RedHill Biopharma to maximize Opaganib Phase 2/3 COVID-19 Clinical Data

Veeva Vault CDMS and Bioforum selected to optimize clinical data management for RedHill’s global Phase 2/3 clinical trial ...
Sep 25

CHMP recommends approval of Supemtek for the prevention of influenza in adults aged 18 and above

CHMP has adopted a positive opinion for Supemtek for active immunization for the prevention of influenza in adults...
Sep 23

Johnson & Johnson initiates phase 3 clinical trial for COVID-19 vaccine Candidate

The Company is committed to bringing an affordable vaccine to the public on a not-for-profit basis for emergency pandemic use...
Sep 23

Vaxart announces FDA clearance of IND application for oral COVID-19 Vaccine

Oral Covid vaccine gains ground...
Sep 18

Vaccine nationalism puts lives at risk says European Union chief

In her first annual State of the European Union address, Ursula von der Leyen said the coronavirus pandemic ...
Sep 17

AstraZeneca to start Phase 3 trials of COVID vaccine in United States

AstraZeneca closer to COVID vaccine as 3rd phase trial starts...
Sep 01

FUJIFILM to support COVID-19 vaccine candidate manufacturing

FUJIFILM Diosynth Biotechnologies will support COVID-19 vaccine candidate manufacturing, as part of Operation Warp Speed, a U.S. government program...
Jul 31

BD partners with U.S. Government for Mass Vaccination campaign

...
Jul 17

25 Matching result(s) found!

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024